BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 30919077)

  • 61. Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population.
    Bergman L; Nilsson B; Lundell G; Lundell M; Seregard S
    Ophthalmology; 2005 May; 112(5):834-40. PubMed ID: 15878063
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Conservative biopsy excision and management of a large iris melanoma.
    Chong CF; Patel DV; Hadden PW; McGhee CNj
    Clin Exp Optom; 2014 May; 97(3):278-9. PubMed ID: 24117749
    [No Abstract]   [Full Text] [Related]  

  • 63. Uveal and conjunctival malignant melanoma in denmark 1943-97: observed and relative survival of patients followed through 2002.
    Isager P; Engholm G; Overgaard J; Storm H
    Ophthalmic Epidemiol; 2006 Apr; 13(2):85-96. PubMed ID: 16581612
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Ocular retention in patients with uveal melanoma managed by a multimodality approach].
    García-Alvarez C; Muiños Y; Saornil MA; Almaraz A; López-Lara F; Frutos JM; Muñoz MF
    Arch Soc Esp Oftalmol; 2009 Mar; 84(3):145-9. PubMed ID: 19340720
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Outcomes of treatment with stereotactic radiosurgery or proton beam therapy for choroidal melanoma.
    Sikuade MJ; Salvi S; Rundle PA; Errington DG; Kacperek A; Rennie IG
    Eye (Lond); 2015 Sep; 29(9):1194-8. PubMed ID: 26160531
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Melanoma of the iris with recurrent hyphema--course over 32 years].
    Schmidbauer JM; Burk RO; Daus W; Völcker HE
    Klin Monbl Augenheilkd; 1993 Aug; 203(2):117-20. PubMed ID: 8231044
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Uveal melanoma in teenagers and children. A report of 40 cases.
    Shields CL; Shields JA; Milite J; De Potter P; Sabbagh R; Menduke H
    Ophthalmology; 1991 Nov; 98(11):1662-6. PubMed ID: 1800926
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [A woman with iris heterochromia].
    Birker IL; Boons LS; Luyten GP
    Ned Tijdschr Geneeskd; 2016; 160():D197. PubMed ID: 27334084
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Plaque radiotherapy treatment with ruthenium-106 for iris malignant melanoma.
    Tsimpida M; Hungerford J; Arora A; Cohen V
    Eye (Lond); 2011 Dec; 25(12):1607-11. PubMed ID: 21941358
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effects of proton beam irradiation on uveal melanomas: a comparative study of Ki-67 expression in irradiated versus non-irradiated melanomas.
    Chiquet C; Grange JD; Ayzac L; Chauvel P; Patricot LM; Devouassoux-Shisheboran M
    Br J Ophthalmol; 2000 Jan; 84(1):98-102. PubMed ID: 10611107
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Diagnosis and Therapy of Iris Lesions].
    Mor JM; Koch KR; Heindl LM
    Klin Monbl Augenheilkd; 2017 Dec; 234(12):1541-1554. PubMed ID: 29156467
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Suspected vitreous seeding of uveal melanoma: relevance of diagnostic vitrectomy.
    Metz CH; Bornfeld N; Metz KA; Gök M
    Br J Ophthalmol; 2016 May; 100(5):660-4. PubMed ID: 26359338
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Uveal melanoma in the first 4 decades of life.
    Sagus M; Bedikian AY
    South Med J; 2015 Mar; 108(3):158-63. PubMed ID: 25772049
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Iodine brachytherapy as an alternative to enucleation for large uveal melanomas.
    Puusaari I; Heikkonen J; Summanen P; Tarkkanen A; Kivelä T
    Ophthalmology; 2003 Nov; 110(11):2223-34. PubMed ID: 14597534
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Metastatic melanoma in the eye and orbit.
    Zografos L; Ducrey N; Beati D; Schalenbourg A; Spahn B; Balmer A; Othenin-Girard CB; Chamot L; Egger E
    Ophthalmology; 2003 Nov; 110(11):2245-56. PubMed ID: 14597536
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Iris melanomas. A retrospective study of 11 patients treated by surgical excision].
    Cardine S; Labetoulle M; Kirsch O; Di Nolfo M; Offret H; Frau E
    J Fr Ophtalmol; 2003 Jan; 26(1):31-7. PubMed ID: 12610407
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Survival of patients with recurrent uveal melanoma after treatment with radiation therapy.
    Lane AM; Hartley C; Go AK; Wu F; Gragoudas ES; Kim IK
    Br J Ophthalmol; 2024 May; 108(5):729-734. PubMed ID: 37402487
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Iris melanoma: features and prognosis in 317 children and adults.
    Shields CL; Kaliki S; Shah SU; Luo W; Furuta M; Shields JA
    J AAPOS; 2012 Feb; 16(1):10-6. PubMed ID: 22370659
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Survival rates with uveal melanoma in the United States: 1973-1997.
    Singh AD; Topham A
    Ophthalmology; 2003 May; 110(5):962-5. PubMed ID: 12750098
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Local recurrence after uveal melanoma proton beam therapy: recurrence types and prognostic consequences.
    Caujolle JP; Paoli V; Chamorey E; Maschi C; Baillif S; Herault J; Gastaud P; Hannoun-Levi JM
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1218-24. PubMed ID: 23177670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.